Garcinia xanthochymus benzophenones promote hyphal apoptosis and potentiate activity of fluconazole against Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 10, 2015, Pages 6032-6038

  Jackson, Desmond N ^a   Yang, Lin ^a,b   Wu, ShiBiao ^c   Kennelly, Edward J ^b,c   Lipke, Peter N ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BENZOPHENONE DERIVATIVE; CASPOFUNGIN; FLUCONAZOLE; FUNGAL DNA; GARCINOL; PHOSPHATIDYLSERINE; PLANT EXTRACT; UNCLASSIFIED DRUG; XANTHOCHYMOL; DRUG COMBINATION; TERPENE;

ANTIFUNGAL SUSCEPTIBILITY; APOPTOSIS; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DNA FRAGMENTATION; DRUG POTENTIATION; EC50; FRUIT; FUNGAL VIABILITY; FUNGICIDAL ACTIVITY; FUNGUS HYPHAE; GARCINIA; GARCINIA XANTHOCHYMUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TIME LAPSE IMAGING; TUNEL ASSAY; YEAST CELL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; APOPTOSIS; BENZOPHENONES; BIOFILMS; CANDIDA ALBICANS; DNA FRAGMENTATION; DRUG COMBINATIONS; DRUG SYNERGISM; FLUCONAZOLE; FRUIT; GARCINIA; HYPHAE; IN SITU NICK-END LABELING; MICROBIAL SENSITIVITY TESTS; PHOSPHATIDYLSERINES; PLANT EXTRACTS; TERPENES;

EID: 84942257488     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00820-15     Document Type: Article

References (51)

1. Odds FC. 1985. Morphogenesis in Candida albicans. Crit Rev Microbiol 12:45-93. http://dx.doi.org/10.3109/10408418509104425.
2. Sudbery P, Gow N, Berman J. 2004. The distinct morphogenic states of Candida albicans. Trends Microbiol 12:317-324. http://dx.doi.org/10.1016/j.tim.2004.05.008.
3. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu Rev Microbiol 49:711-745. http://dx.doi.org/10.1146/annurev.mi.49.100195.003431.
4. Chandra J, Mukherjee PK, Ghannoum MA. 2008. In vitro growth and analysis of Candida biofilms. Nat Protoc 3:1909-1924. http://dx.doi.org/10.1038/nprot.2008.192.
5. Gow NA, Brown AJ, Odds FC. 2002. Fungal morphogenesis and host invasion. Curr Opin Microbiol 5:366-371. http://dx.doi.org/10.1016/S1369-5274(02)00338-7.
6. Wachtler B, Wilson D, Haedicke K, Dalle F, Hube B. 2011. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 6:e17046. http://dx.doi.org/10.1371/journal.pone.0017046.
7. Mukherjee PK, Chandra J. 2004. Candida biofilm resistance. Drug Resist Updat 7:301-309. http://dx.doi.org/10.1016/j.drup.2004.09.002.
8. Nett JE. 2014. Future directions for anti-biofilm therapeutics targeting Candida. Expert Rev Anti Infect Ther 12:375-382. http://dx.doi.org/10.1586/14787210.2014.885838.
9. Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. 2014. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 5:pii=a019752. http://dx.doi.org/10.1101/cshperspect.a019752.
10. Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE, Mitchell AP, Andes DR. 2014. Novel entries in a fungal biofilm matrix encyclopedia. mBio 5:e01333-14. http://dx.doi.org/10.1128/mBio.01333-14.
11. Calderone R, Sun N, Gay-Andrieu F, Groutas W, Weerawarna P, Prasad S, Alex D, Li D. 2014. Antifungal drug discovery: the process and outcomes. Future Microbiol 9:791-805. http://dx.doi.org/10.2217/fmb.14.32.
12. Acuña UM, Dastmalchi K, Basile MJ, Kennelly EJ. 2012. Quantitative high-performance liquid chromatography photodiode array (HPLC-PDA) analysis of benzophenones and biflavonoids in eight Garcinia species. J Food Compos Anal 25:215-220. http://dx.doi.org/10.1016/j.jfca.2011.10.006.
13. Zhang LJ, Chiou CT, Cheng JJ, Huang HC, Kuo LM, Liao CC, Bastow KF, Lee KH, Kuo YH. 2010. Cytotoxic polyisoprenyl benzophenonoids from Garcinia subelliptica. J Nat Prod 73:557-562. http://dx.doi.org/10.1021/np900620y.
14. Acuña UM, Figueroa M, Kavalier A, Jancovski N, Basile MJ, Kennelly EJ. 2010. Benzophenones and biflavonoids from Rheedia edulis. J Nat Prod 73:1775-1779. http://dx.doi.org/10.1021/np100322d.
15. Baggett S, Protiva P, Mazzola EP, Yang H, Ressler ET, Basile MJ, Weinstein IB, Kennelly EJ. 2005. Bioactive benzophenones from Garcinia xanthochymus fruits. J Nat Prod 68:354-360. http://dx.doi.org/10.1021/np0497595.
16. Matsumoto K, Akao Y, Kobayashi E, Ito T, Ohguchi K, Tanaka T, Iinuma M, Nozawa Y. 2003. Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull 26:569-571. http://dx.doi.org/10.1248/bpb.26.569.
17. Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, Kundu TK. 2004. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279:33716-33726. http://dx.doi.org/10.1074/jbc.M402839200.
18. Simonetti G, Passariello C, Rotili D, Mai A, Garaci E, Palamara AT. 2007. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res 7:1371-1380. http://dx.doi.org/10.1111/j.1567-1364.2007.00276.x.
19. Dahlin JL, Sinville R, Solberg J, Zhou H, Han J, Francis S, Strasser JM, John K, Hook DJ, Walters MA, Zhang Z. 2013. A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation. PLoS One 8:e78877. http://dx.doi.org/10.1371/journal.pone.0078877.
20. Roux D, Hadi HA, Thoret S, Guenard D, Thoison O, Pais M, Sevenet T. 2000. Structure-activity relationship of polyisoprenyl benzophenones from Garcinia pyrifera on the tubulin/microtubule system. J Nat Prod 63:1070-1076. http://dx.doi.org/10.1021/np0000872.
21. Varalakshmi KN, Sangeetha CG, Shabeena AN, Sunitha SR, Vapika J. 2010. Antimicrobial and cytotoxic effects of Garcinia indica fruit rind extract. American-Eurasian J Agric Environ Sci 7:652-656.
22. Norice CT, Smith FJ, Jr, Solis N, Filler SG, Mitchell AP. 2007. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot Cell 6:2046-2055. http://dx.doi.org/10.1128/EC.00314-07.
23. Yang H, Figueroa M, To S, Baggett S, Jiang B, Basile MJ, Weinstein IB, Kennelly EJ. 2010. Benzophenones and biflavonoids from Garcinia livingstonei fruits. J Agric Food Chem 58:4749-4755. http://dx.doi.org/10.1021/jf9046094.
24. Pierce CG, Uppuluri P, Tummala S, Lopez-Ribot JL. 2010. A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp 44:pii=2287. http://dx.doi.org/10.3791/2287.
25. Pierce CG, Saville SP, Lopez-Ribot JL. 2014. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation. Pathog Dis 70:423-431. http://dx.doi.org/10.1111/2049-632X.12161.
26. Hao B, Cheng S, Clancy CJ, Nguyen MH. 2013. Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis. Antimicrob Agents Chemother 57:326-332. http://dx.doi.org/10.1128/AAC.01366-12.
27. Rieger AM, Hall BE, Luong LT, Schang LM, Barreda DR. 2010. Conventional apoptosis assays using propidium iodide generate a significant number of false positives that prevent accurate assessment of cell death. J Immunol Methods 358:81-92. http://dx.doi.org/10.1016/j.jim.2010.03.019.
28. Jin Y, Zhang T, Samaranayake YH, Fang HH, Yip HK, Samaranayake LP. 2005. The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 159:353-360. http://dx.doi.org/10.1007/s11046-004-6987-7.
29. Protiva P, Hopkins ME, Baggett S, Yang H, Lipkin M, Holt PR, Kennelly EJ, Bernard WI. 2008. Growth inhibition of colon cancer cells by polyisoprenylated benzophenones is associated with induction of the endoplasmic reticulum response. Int J Cancer 123:687-694. http://dx.doi.org/10.1002/ijc.23515.
30. Traven A, Janicke A, Harrison P, Swaminathan A, Seemann T, Beilharz TH. 2012. Transcriptional profiling of a yeast colony provides new insight into the heterogeneity of multicellular fungal communities. PLoS One 7:e46243. http://dx.doi.org/10.1371/journal.pone.0046243.
31. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71:4333-4340.
32. Lamfon H, Porter SR, McCullough M, Pratten J. 2004. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 53:383-385. http://dx.doi.org/10.1093/jac/dkh071.
33. Nobile CJ, Nett JE, Andes DR, Mitchell AP. 2006. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5:1604-1610. http://dx.doi.org/10.1128/EC.00194-06.
34. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat Rev Microbiol 9:737-748. http://dx.doi.org/10.1038/nrmicro2636.
35. Mao, X, Li, Y, Wang, H, Cao, F, Chen, J. 2008. Antagonistic interplay of Swi1 and Tup1 on filamentous growth of Candida albicans. FEMS Microbiol Lett 285:233-241. http://dx.doi.org/10.1111/j.1574-6968.2008.01236.x.
36. Lu Y, Su C, Mao X, Raniga PP, Liu H, Chen J. 2008. Efg1-mediated recruitment of NuA4 to promoters is required for hypha-specific Swi/Snf binding and activation in Candida albicans. Mol Biol Cell 19:4260-4272. http://dx.doi.org/10.1091/mbc.E08-02-0173.
37. Lu Y, Su C, Wang A, Liu H. 2011. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance. PLoS Biol 9:e1001105. http://dx.doi.org/10.1371/journal.pbio.1001105.
38. Imanishi Y, Yokoyama K, Nishimura K. 2004. Inductions of germ tube and hyphal formations are controlled by mRNA synthesis inhibitor in Candida albicans. Nihon Ishinkin Gakkai Zasshi 45:113-119.
39. Kumar S, Chattopadhyay SK, Darokar MP, Garg A, Khanuja SP. 2007. Cytotoxic activities of xanthochymol and isoxanthochymol substantiated by LC-MS/MS. Planta Med 73:1452-1456. http://dx.doi.org/10.1055/s-2007-990255.
40. Al-Dhaheri RS, Douglas LJ. 2010. Apoptosis in Candida biofilms exposed to amphotericin B. J Med Microbiol 59:149-157. http://dx.doi.org/10.1099/jmm.0.015784-0.
41. Madeo F, Carmona-Gutierrez D, Ring J, Buttner S, Eisenberg T, Kroemer G. 2009. Caspase-dependent and caspase-independent cell death pathways in yeast. Biochem Biophys Res Commun 382:227-231. http://dx.doi.org/10.1016/j.bbrc.2009.02.117.
42. Cao Y, Huang S, Dai B, Zhu Z, Lu H, Dong L, Cao Y, Wang Y, Gao P, Chai Y, Jiang Y. 2009. Candida albicans cells lacking CaMCA1-encoded metacaspase show resistance to oxidative stress-induced death and change in energy metabolism. Fungal Genet Biol 46:183-189. http://dx.doi.org/10.1016/j.fgb.2008.11.001.
43. Sharma M, Manoharlal R, Puri N, Prasad R. 2010. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci Rep 30:391-404. http://dx.doi.org/10.1042/BSR20090151.
44. Cuesta-Rubio O, Frontana-Uribe BA, Ramirez-Apan T, Cardenas J. 2002. Polyisoprenylated benzophenones in Cuban propolis: biological activity of nemorosone. Z Naturforsch C 57:372-378.
45. Sorgo AG, Heilmann CJ, Dekker HL, Bekker M, Brul S, de Koster CG, de Koning LJ, Klis FM. 2011. Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans. Eukaryot Cell 10:1071-1081. http://dx.doi.org/10.1128/EC.05011-11.
46. Bujdáková H, Kulkova N, Cernakova L. 2012. Susceptibility to caspofungin and fluconazole and Als1/Als3 gene expression in biofilm and dispersal cells of Candida albicans. Arh Hig Rada Toksikol 63:497-503. http://dx.doi.org/10.2478/10004-1254-63-2012-2236.
47. Walraven CJ, Bernardo SM, Wiederhold NP, Lee SA. 2014. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Med Mycol 52:131-139. http://dx.doi.org/10.1093/mmy/myt007.
48. Yang W, Yan L, Wu C, Zhao X, Tang J. 2014. Fungal invasion of epithelial cells. Microbiol Res 169:803-810. http://dx.doi.org/10.1016/j.micres.2014.02.013.
49. Wilson D, Mayer FL, Miramon P, Citiulo F, Slesiona S, Jacobsen ID, Hube B. 2014. Distinct roles of Candida albicans-specific genes in host-pathogen interactions. Eukaryot Cell 13:977-989. http://dx.doi.org/10.1128/EC.00051-14.
50. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. 2012. Candida albicans morphogenesis and host defense: discriminating invasion from colonization. Nat Rev Microbiol 10:112-122. http://dx.doi.org/10.1038/nrmicro2711.
51. Berman J, Sudbery PE. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3:918-930. http://dx.doi.org/10.1038/nrg948.